Godshalk Welsh Capital Management’s Celgene Corp CELG Stock Holding History

Godshalk Welsh Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,410	Closed	-$252K	–	122
2017 Q4	$252K	Sell	2,410 -200	-8%	-$22.6K	0.26%	105
2017 Q3	$381K	Hold	2,610	–	–	0.38%	91
2017 Q2	$339K	Hold	2,610	–	–	0.34%	100
2017 Q1	$325K	Sell	2,610 -50	-2%	-$5.98K	0.32%	105
2016 Q4	$308K	Hold	2,660	–	–	0.32%	103
2016 Q3	$278K	Sell	2,660 -56	-2%	-$6.06K	0.29%	107
2016 Q2	$268K	Sell	2,716 -200	-7%	-$20.7K	0.28%	112
2016 Q1	$292K	Hold	2,916	–	–	0.3%	106
2015 Q4	$349K	Sell	2,916 -200	-6%	-$23.1K	0.36%	97
2015 Q3	$337K	Buy	3,116 +200	+7%	+$24.8K	0.37%	99
2015 Q2	$337K	Sell	2,916 -700	-19%	-$80K	0.34%	104
2015 Q1	$417K	Hold	3,616	–	–	0.43%	89
2014 Q4	$404K	Buy	+3,616	New	+$381K	0.37%	93

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Godshalk Welsh Capital Management's CELG Position: Q1 2018 in Review

Godshalk Welsh Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,410 shares — an estimated $252K sold.

Godshalk Welsh Capital Management first reported a position in CELG in Q4 2014 and held it in 13 quarters. The position peaked at $417K in Q1 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Godshalk Welsh Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Godshalk Welsh Capital Management sold 2,410 Celgene Corp shares in Q1 2018, an estimated $252K.
Godshalk Welsh Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 13 quarters.
Godshalk Welsh Capital Management's Celgene Corp position peaked at $417K in Q1 2015.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2018, filed 10 May 2018.